Morpholine

Morpholine

SCHEMBL7984416

C1COCCN1.CCOc1c(C)cc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)cc1C

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.52
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 1/20 0.37
BRD4 O60885 5/20 0.36
P2RX7 Q99572 2/20 0.34
PRMT5 O14744 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Morpholine SCHEMBL7991505 0.87 KMT2A (0.55) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
Morpholine SCHEMBL7988796 0.87 KMT2A (0.52) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7984961 0.82 HPGD (0.48) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7984883 0.79 SMN1; SMN2 (0.54) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7985321 0.79 SMN1; SMN2 (0.55) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7974476 0.77 GUSB (0.56) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7974404 0.77 SMN1; SMN2 (0.49) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7985282 0.76 ALDH1A1 (0.41) KMT2AHPGDSMN1; SMN2ALDH1A1BRD4
SCHEMBL7975265 0.75 SMN1; SMN2 (0.61) KMT2AHPGDSMN1; SMN2ALDH1A1GAA
SCHEMBL7985355 0.75 GAA (0.56) KMT2AHPGDSMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed